Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: experience at a tertiary care centre in oman.

The Open Cardiovascular Medicine Journal Pub Date : 2013-11-29 eCollection Date: 2013-01-01 DOI:10.2174/1874192401307010122
H Farhan, A Albulushi, A Taqi, A Al-Hashim, K Al-Saidi, K Al-Rasadi, A Al-Mazroui, I Al-Zakwani
{"title":"Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: experience at a tertiary care centre in oman.","authors":"H Farhan,&nbsp;A Albulushi,&nbsp;A Taqi,&nbsp;A Al-Hashim,&nbsp;K Al-Saidi,&nbsp;K Al-Rasadi,&nbsp;A Al-Mazroui,&nbsp;I Al-Zakwani","doi":"10.2174/1874192401307010122","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy.</p><p><strong>Methods: </strong>A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman.</p><p><strong>Results: </strong>The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the patients were female. There were 11 (19%) cases of thyroid dysfunction (TD). Seven (12%) patients were hypothyroid, 3 (5%) had hyperthyroidism and 1 (2%) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05).</p><p><strong>Conclusion: </strong>Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.</p>","PeriodicalId":504447,"journal":{"name":"The Open Cardiovascular Medicine Journal","volume":"7 ","pages":"122-6"},"PeriodicalIF":0.0000,"publicationDate":"2013-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/45/fd/TOCMJ-7-122.PMC3866614.pdf","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Cardiovascular Medicine Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874192401307010122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy.

Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman.

Results: The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the patients were female. There were 11 (19%) cases of thyroid dysfunction (TD). Seven (12%) patients were hypothyroid, 3 (5%) had hyperthyroidism and 1 (2%) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05).

Conclusion: Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.

慢性胺碘酮治疗患者甲状腺功能障碍的发生率和模式:阿曼三级保健中心的经验。
目的:了解慢性胺碘酮治疗患者甲状腺功能障碍(TD)的发生率和类型。方法:回顾性分析2007年10月至2010年10月3年间59例定期接受胺碘酮治疗至少12个月的患者。这些患者在阿曼马斯喀特苏丹卡布斯大学医院的心脏诊所接受了随访。结果:队列患者平均年龄为63±13岁,年龄范围为27 ~ 98岁。51% (n = 30)患者为女性。甲状腺功能障碍(TD) 11例(19%)。甲状腺功能减退7例(12%),甲亢3例(5%),亚临床甲状腺功能减退1例(2%);无亚临床甲状腺功能亢进病例。女性性别和抗甲状腺过氧化物酶抗体的存在与胺碘酮诱导的甲状腺功能减退有显著相关性(p = 0.001),而年龄、胺碘酮剂量和治疗时间与TD的发生无相关性(p值均> 0.05)。结论:胺碘酮所致甲状腺功能障碍普遍存在。甲状腺功能减退在女性患者和抗甲状腺过氧化物酶抗体阳性的患者中更为常见。所有接受胺碘酮治疗的患者都必须进行甲状腺功能的初步筛查和定期监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信